GLP-1 drugs are changing the landscape of diabetes and obesity management, but they may also have implications for mental health
What is particularly challenging (and well-known to those aware of the pharmaceutical industrys history) is how the label safe and effective can sometimes conceal rare but devastating side effects
It is associated with drawbacks such as injection pain, injection site dystrophy, inconvenience, social distress and/or injection phobia
My doctor explained it was a relatively new medication so there were some unknowns and potential risks, such as, in rare cases, thyroid cancer, and stomach upset, but she was confident Mounjaro would help me lose weight
Glucagon like peptide-1 (GLP-1) is the natural ligand of GLP-1R
Photograph affected areas in consistent lighting